These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363 [TBL] [Abstract][Full Text] [Related]
23. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049 [TBL] [Abstract][Full Text] [Related]
24. C5a-C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms. Okada A; Shimizu K; Kawashima A; Kayahara T; Itani M; Kurita H; Miyamoto S; Kataoka H; Aoki T Sci Rep; 2024 Feb; 14(1):3105. PubMed ID: 38326494 [TBL] [Abstract][Full Text] [Related]
25. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury. Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505 [TBL] [Abstract][Full Text] [Related]
26. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells. Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852 [TBL] [Abstract][Full Text] [Related]
27. Complement C5a Receptor 1 Exacerbates the Pathophysiology of Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO mBio; 2018 Jan; 9(1):. PubMed ID: 29362231 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of activation and biased signaling in complement receptor C5aR1. Feng Y; Zhao C; Deng Y; Wang H; Ma L; Liu S; Tian X; Wang B; Bin Y; Chen P; Yan W; Fu P; Shao Z Cell Res; 2023 Apr; 33(4):312-324. PubMed ID: 36806352 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function. Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759 [TBL] [Abstract][Full Text] [Related]
30. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432 [TBL] [Abstract][Full Text] [Related]
31. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ. Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369 [TBL] [Abstract][Full Text] [Related]
39. Discovery and Characterization of a New Class of C5aR1 Antagonists Showing Hubler F; Renneberg D; Siendt H; Stamm S; Hilpert K; Caroff E; Delahaye S; Froidevaux S; Murphy MJ J Med Chem; 2024 Mar; 67(5):4100-4119. PubMed ID: 38482828 [TBL] [Abstract][Full Text] [Related]
40. C5aR2 Deficiency Lessens C5aR1 Distribution and Expression in Neutrophils and Macrophages. Zhang T; Ma N; Wang J; Min X; Wei L; Li K J Immunol Res; 2024; 2024():2899154. PubMed ID: 39021433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]